Frías, M
Rodríguez-Cano, D
Cuenca-López, F
Macías, J
Gordon, A
Manzanares-Martín, B
Pineda, J A
Camacho, Á
Torre-Cisneros, J
Peña, J
Rivero-Juárez, A
Rivero, A
Article History
First Online: 25 October 2016
Competing interests
: AR received consulting fees from Bristol-Myers Squibb, Abbott, Gilead, Roche, Boehringer Ingelheim, GlaxoSmithKline, Merck Sharp & Dohme, and Janssen-Cilag. He also received lecture fees from GlaxoSmithKline, Roche, Abbott, Bristol-Myers Squibb, Boehringer Ingelheim and Schering-Plough. The remaining authors declare no conflict of interest.